Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants

Lewis Paul; Tharp Jennifer L.

首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants

【24h】

Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants

机译：在直接口服抗凝血剂上突破五位Covid-19患者的静脉血栓栓塞事件

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

What is known and objective Coronavirus disease 2019 (COVID-19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization.

机译：已知和客观的2019年冠状病毒病（COVID-19）与静脉血栓栓塞（VTE）风险增加有关。VTE预防指南继续发展，包括在住院后继续使用直接口服抗凝剂（DOAC）。

著录项

来源
《Journal of Clinical Pharmacy and Therapeutics》 |2021年第2期|共5页
作者
Lewis Paul; Tharp Jennifer L.;
展开▼
作者单位

Johnson City Med Ctr Dept Pharm 400 North State Franklin Rd Johnson City TN 37604 USA;

Johnson City Med Ctr Dept Pharm 400 North State Franklin Rd Johnson City TN 37604 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
factor Xa Inhibitors; heparin; low molecular weight; pulmonary embolism; SARSamp; 8208; CoVamp; 8208; 2;

机译：因子XA抑制剂;肝素;低分子量;肺栓塞;SARS＆amp;8208;COV＆amp;8208;2;

相似文献

外文文献
中文文献
专利

1. A Literature Review of Antithrombotic Therapy for Patients of Venous Thromboembolic Events with Comorbidity of Coronary Heart Disease [J] . Mengxin Zhou, Rui Sun, Yuexin Chen 中国医学科学杂志（英文版） . 2018,第002期
2. Pourquoi et comment utiliser les anticoagulants oraux directs (AOD) dans la maladie thromboembolique veineuse (MTEV) ? Why and how to use the Direct Oral Anticoagulants (DOA) for the treatment of venous thromboembolic events? [J] . A. Rossi, I. Mahe Archives of cardiovascular diseases. Supplements . 2016,第4期

机译：为什么以及如何在静脉血栓栓塞症（VTE）中使用直接口服抗凝剂（DOA）？为什么以及如何使用直接口服抗凝剂（DOA）来治疗静脉血栓栓塞事件？
3. Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms [J] . Huenerbein Karlo, Sadjadian Parvis, Becker Tatjana, Annals of hematology . 2021,第8期

机译：直接口服抗凝血剂（DOAC）用于预防髓原肿瘤中的复发动脉或静脉血栓栓塞事件（ATE / VTE）
4. Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants [J] . Wallvik Niklas, Renlund Henrik, Sjalander Anders Journal of thrombosis and thrombolysis . 2021,第1期

机译：用新的口腔抗凝血剂治疗静脉血栓栓塞事件的患者出血风险
5. Development and Assessment of RecosDoc-MTeV to Improve the Quality of Direct Oral Anticoagulant Prescription for Venous Thromboembolic Disease. [C] . Brigitte Séroussi, Houda Ouarrirh, Isma?l Elalamy, MEDINFO . 2019

机译：RecoSdoc-MTEV的开发和评估改善静脉血栓栓塞术治疗直接口服抗凝药物的质量。
6. Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants [D] . Manzoor, Beenish S. 2017

机译：从精密医学到直接口服抗凝剂的抗凝剂导航安全性
7. Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia [O] . Evelien Krumb, Cedric Hermans 2021

机译：严重遗传血栓管患者直接口服抗凝剂的静脉血栓栓塞疾病的主要预防
8. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease [O] . J. Shaw, C. de Wit, G. Le Gal, 2017

机译：在静脉血栓栓塞患者术后直接口服抗凝血剂的围手术期中断后血栓和出血结果
9. Global Evacuation of Burn Patients Does Not Increase the Incidence of Venous Thromboembolic Complications. [R] . Chung, K. K., Blackbourne, L. H., Renz, E. M., 2008

机译：烧伤患者的全球疏散不会增加静脉血栓栓塞并发症的发生率。

Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants

摘要

著录项

相似文献

相关主题

期刊订阅